Guidelines for the investigation of efficacy in social anxiety disorder. ECNP Consensus Meeting
dc.contributor.author | Montgomery SA | |
dc.contributor.author | Lecrubier Y | |
dc.contributor.author | Baldwin DS | |
dc.contributor.author | Kasper S | |
dc.contributor.author | Lader M | |
dc.contributor.author | Nil R | |
dc.contributor.author | Stein DJ | |
dc.contributor.author | Van Ree JM | |
dc.date.accessioned | 2013-01-23T14:11:39Z | |
dc.date.available | 2013-01-23T14:11:39Z | |
dc.date.issued | 2004 | |
dc.description | Gesondheidswetenskappe | |
dc.description | Psigiatrie | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.identifier.citation | European Neuropsychopharmacology | |
dc.identifier.uri | http://hdl.handle.net/10019.1/79249 | |
dc.publisher | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |
dc.title | Guidelines for the investigation of efficacy in social anxiety disorder. ECNP Consensus Meeting | |
dc.type | Journal Articles (subsidised) |